Estrogen-containing combined hormonal contraceptives are not tied to vascular risk, such as stroke, in women with migraine with and without aura.

Lasmiditan is a promising treatment for menstrual migraine, offering sustained pain relief comparable to or exceeding that of triptans. However, further research is needed to fully assess its safety ...

HealthDay News — Seventeen modifiable risk factors are shared by stroke, dementia, and late-life depression, according to a review published online April 3 in the Journal of Neurology, Neurosurgery & ...

Compared to usual care, telemedicine had no significant effect on neuropsychiatric symptoms in dementia patients in long-term care facilities.

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

The use of lemborexant vs placebo is effective and well-tolerated to treat sleep symptoms among patients with insomnia.

Moderate, heavy, and former heavy alcohol consumption are associated with hyaline arteriolosclerosis and neurofibrillary tangles.

HealthDay News — One in 13 youth and adolescents globally experience nocturnal enuresis, according to a review published online March 20 in Child and Adolescent Psychiatry and Mental Health.

The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.

Results were announced from a phase 3 trial evaluating solriamfetol for major depressive disorder with/without severe excessive daytime sleepiness.

Older Mexican American vs non-Hispanic White adults are more unaware of a dementia diagnosis, highlighting important considerations for physicians.

Osteoarthritis was not associated with cognitive decline, though patients with OA and comorbid depression faced a greater risk for cognitive impairment.